Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 8, 2013

View Archived Issues

A comparative analysis of the structural-antifungal activity of polyene antibiotics

TRK-390 as a novel and highly selective phosphate binder

Results presented for olaparib in EGFR NSCLC and BRCA-mutated ovarian cancer

LC-510201, a new S1P1/S1P5 receptor agonist for multiple sclerosis

AnGes' phase I/II study of HGF gene therapy in primary lymphedema begins in Japan

First-in-human data for the human monoclonal antibody KRN-23

Presentations describe preclinical data on hepatitis B treatment candidate bentysrepinine

HSV-2 vaccine protective in animal challenge model

Novel myostatin inhibitors patented

Vitae Pharmaceuticals presents new liver X receptor-beta agonists

Novel metabotropic glutamate mGlu2 receptor PAMs disclosed by Bristol-Myers Squibb

Dual orexin receptor antagonists discovered at Rottapharm

ConfirmMDx prostate cancer test meets primary endpoints in clinical validation study

Joslin Diabetes Center partners with Pfizer and Lilly

Researchers use DNA nanotechnology to develop super-high-resolution molecular imaging

Poxel reports data for imeglimin from human hyperglycemic clamp trial

FDA accepts IND application for LGD-6972 in type 2 diabetes

Ampio Pharmaceuticals reports results from independent panel review of Optina trial

GSK adds development candidate to its collaboration with Isis

Kitasato Institute and Tella to collaborate on dendritic cell vaccine study

Effimune and Janssen Biotech sign option and license agreement for FR-104

Immutep and Eddingpharm sign agreement for ImmuFact IMP-321 in China

Chugai seeks approval of alectinib hydrochloride in Japan

Eleison initiates phase III study of glufosfamide for second-line treatment of pancreatic cancer

Phase II study of Novavax's respiratory syncytial virus vaccine begins

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
European Commission floats multiple fixes for MDR, IVDR
BioWorld MedTech
The European Union’s struggles with regulations for devices and in vitro diagnostics seem virtually endless, but the European Commission floated a series of...
ATNM-400 radioconjugate shows efficacy in resistant breast cancer
BioWorld Science
Although hormone receptor-positive (HR+) breast cancer accounts for over 70% of cases, 20%-30% of patients still experience relapse despite endocrine therapies...